UK spotlight on endoscopy performance:
This article was originally published in Clinica
"Nurse endoscopists are cheaper, significantly more thorough, and better appreciated by patients, but doctors achieve better outcomes at one year and, overall, are likely to be more cost-effective." This is the leading conclusion of the UK's Multi-Institution Nurse Endoscopy Trial (MINuET), commissioned by the National Co-ordinating Centre for Health Technology Assessment. The research, published by the NCCHTA on October 17, was headed by Professor John Williams, of the University of Wales in Swansea.
You may also be interested in...
With positive data from two Phase III trials, Incyte hopes to file an NDA this year for topical Jakafi in mild-to-moderate AD.
Emerging Company Profile: Axcella uses Generally Recognized As Safe (GRAS) amino acids to create drug candidates for hepatic encephalopathy, NASH and other diseases.
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.